Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Atara Biotherapeutics (ATRA) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to 4.53.

  • Atara Biotherapeutics' Asset Utilization Ratio rose 48637.57% to 4.53 in Q3 2025 from the same period last year, while for Sep 2025 it was 4.53, marking a year-over-year increase of 48637.57%. This contributed to the annual value of 0.94 for FY2024, which is 286817.52% up from last year.
  • Atara Biotherapeutics' Asset Utilization Ratio amounted to 4.53 in Q3 2025, which was up 48637.57% from 3.81 recorded in Q2 2025.
  • In the past 5 years, Atara Biotherapeutics' Asset Utilization Ratio registered a high of 4.53 during Q3 2025, and its lowest value of 0.02 during Q3 2023.
  • In the last 4 years, Atara Biotherapeutics' Asset Utilization Ratio had a median value of 0.33 in 2024 and averaged 1.13.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 7165.34% in 2023, then surged by 360181.27% in 2024.
  • Quarter analysis of 4 years shows Atara Biotherapeutics' Asset Utilization Ratio stood at 0.17 in 2022, then tumbled by 71.65% to 0.05 in 2023, then soared by 2016.18% to 1.02 in 2024, then skyrocketed by 342.38% to 4.53 in 2025.
  • Its Asset Utilization Ratio was 4.53 in Q3 2025, compared to 3.81 in Q2 2025 and 2.33 in Q1 2025.